- Our Story
- Our Products
- Our Science
- Our People & Citizenship
-
Investors
- Reports and Filings
- Presentations & Earnings Calls
-
Shares
- Share Price
- Stock Updates
- Equity & Dividend History
- Unpaid & Unclaimed Dividend
- Analyst Coverage
- Shareholding Pattern
- Share Transfer Information
- Buyback
- Details of Shares for transfer to IEPF May 2018
- Notice pursuant to IEPF Rules, May 2018
- Details of Shares for transfer to IEPF May 2019
- Notice Pursuant to IEPF Rules, May 2019
- Details of Shares for transfer to IEPF May 2020
- Notice pursuant to IEPF Rules, May 2020
- Details of Shares for transfer to IEPF May 2021
- Notice pursuant to IEPF Rules, May 2021
- Governance
- Investor Services
-
ESG profile
- Media
- Partners
- Contact Us
Dr. Reddy's in the news
-
Purple Health a platform for innovation
Click Here for the Complete Story [PDF Format] -
Good Health Can't Wait
Click Here for the Complete Story [PDF Format] -
In Next 3-4 Years, We’ll Have Biosimilars in Emerging Markets – G V Prasad
Click Here for the Complete Story [PDF Format] -
Driving Strategic Growth
Click Here for the Complete Story [PDF Format] -
A People’s Person – Saumen Chakraborty
Click Here for the Complete Story [PDF Format] -
Reshaping an emerging-market giant – Interview with G V Prasad
Click Here for the Complete Story [PDF Format] -
Our focus : Products that are difficult to make
Click Here for the Complete Story [PDF Format]
